Daniel Chu Joins 23andMe as Chief Product Officer
September 19, 2022 06:45 ET
|
23andMe Holding Co.
SUNNYVALE, Calif., Sept. 19, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, today appointed Daniel Chu as Chief Product...
23andMe Reports FY2023 First Quarter Financial Results
August 08, 2022 16:05 ET
|
23andMe Holding Co.
First quarter revenue grew 9% to $64.5 millionConsumer revenue grew 17% year over year due to the addition of telehealth revenueOn track to achieve FY2023 financial guidance SOUTH SAN FRANCISCO,...
23andMe to Report FY2023 First Quarter Financial Results
July 25, 2022 16:05 ET
|
23andMe Holding Co.
SOUTH SAN FRANCISCO, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, announced today that it will report...
23andMe Reports FY2022 Fourth Quarter and Full Year Financial Results
May 26, 2022 16:05 ET
|
23andMe Holding Co.
Achieved FY2022 financial guidanceFourth quarter and full year revenues of $101 million and $272 million representing 14% and 11% increases over prior year, respectivelyNew genomic health services...
23andMe to Report FY2022 Fourth Quarter and Full Year Financial Results
May 12, 2022 16:10 ET
|
23andMe Holding Co.
SUNNYVALE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, announced today that it will report financial...
23andMe to Present at American Association for Cancer Research (AACR) 2022 Annual Meeting
March 15, 2022 06:45 ET
|
23andMe Holding Co.
SUNNYVALE, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and therapeutics company with a mission to help people access,...
23andMe to Present at Cowen 42nd Annual Health Care Conference
February 25, 2022 08:30 ET
|
23andMe Holding Co.
SUNNYVALE, Calif., Feb. 25, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company with a mission to help people access, understand,...
23andMe to Present at Citi’s 2022 Virtual Healthcare Conference
February 17, 2022 09:00 ET
|
23andMe Holding Co.
SUNNYVALE, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company with a mission to help people access, understand,...
23andMe Reports FY2022 Third Quarter Financial Results
February 10, 2022 16:04 ET
|
23andMe Holding Co.
Third quarter revenue of $57 million Therapeutics group advances first wholly-owned immuno-oncology antibody into clinical trials Vision of genetics-based primary care offers potential for millions of...
23andMe to Report FY2022 Third Quarter Financial Results
January 27, 2022 16:05 ET
|
23andMe Holding Co.
SUNNYVALE, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, announced today that it will report financial...